GHRP-2 vs GHRP-6: Comparing Two Growth Hormone Releasing Peptides in Research

·

Dr. James Nguyen, MD

Written by: Dr. James Nguyen, MD (Neurosurgeon)

Growth hormone releasing peptides (GHRPs) are among the oldest synthetic peptide tools in endocrinology. GHRP-6 was described in the early 1980s, and GHRP-2 followed as a more potent analogue. Both act on the same receptor, both stimulate growth hormone (GH) release, and both are still used to study the GH axis and ghrelin signaling.

They are not interchangeable, though. They differ in potency, in how selectively they release GH, and in how strongly they engage appetite pathways. Each of those differences can change what a study measures. This comparison sets out what the published research shows, so researchers can pick the compound that fits their study design.

Introduction: A Shared Receptor, Two Generations

Both peptides act on the growth hormone secretagogue receptor type 1a (GHS-R1a). That receptor was cloned in 1996 by a Merck group, which showed it was expressed in the pituitary and hypothalamus [1]. The GHRPs were synthetic ligands looking for an endogenous partner until 1999, when Kojima and colleagues identified ghrelin, an acylated peptide from the stomach, as the receptor’s natural ligand [2]. GHRP-2 and GHRP-6 are therefore best understood as synthetic ghrelin-receptor agonists, which explains why their effects go beyond GH release.

GHRP-6 Overview

GHRP-6 is a hexapeptide (His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂) developed by Cyril Bowers, Frank Momany, and colleagues. Their 1984 Endocrinology paper reported that it caused dose-related GH release in vitro and in vivo across several species. In those experiments it did not increase LH, FSH, TSH, or prolactin [3].

In a 1990 study of healthy men, GHRP-6 was a potent GH secretagogue and acted synergistically with GHRH: lower amounts given together with GHRH released more GH than either alone. That result supported the idea that GHRPs and GHRH act through separate mechanisms [4]. The same study noted that prolactin and cortisol rose about twofold at the highest exposure tested [4].

GHRP-6 is also known for strong ghrelin-like effects on appetite, which researchers studying feeding behavior have used deliberately.

GHRP-2 Overview

GHRP-2, also known by the nonproprietary name pralmorelin, is a synthetic hexapeptide analogue developed later in the GHRP series. It contains a D-β-naphthylalanine residue and was optimized for potency. In a 1997 study in healthy adults, GHRP-2 produced a strong GH response that exceeded the response to GHRH. It also produced modest increases in prolactin, ACTH, and cortisol. The ACTH and cortisol responses were comparable to those after corticotropin-releasing hormone [5].

GHRP-2 also affects appetite. In a 2005 study in The Journal of Clinical Endocrinology & Metabolism, healthy men ate about 36% more at a buffet meal during a GHRP-2 infusion than during a saline infusion, and every subject increased intake [6]. The authors proposed GHRP-2 as a tool for studying how ghrelin affects eating behavior in humans.

Head-to-Head Comparison

Feature GHRP-2 GHRP-6
Structure Synthetic hexapeptide (contains D-β-Nal) Synthetic hexapeptide (His-D-Trp-Ala-Trp-D-Phe-Lys-NH₂)
Receptor GHS-R1a (ghrelin receptor) agonist GHS-R1a (ghrelin receptor) agonist
Relative potency Higher potency in comparative animal data [7] Lower potency than GHRP-2 [7]
Maximal GH response Lower maximal response than GHRP-6 in swine [7] Higher maximal response than GHRP-2 in swine [7]
ACTH / cortisol Increases reported in humans and swine [5][7] Increases reported in humans and swine [4][7]
Prolactin Modest increases in humans [5] Increase at higher exposures in humans [4]
Appetite / food intake Increased food intake in human study [6] Well-known ghrelin-like appetite effects
Synergy with GHRH Studied with GHRH analogues Synergy shown in humans [4]

Research Findings: What the Comparative Data Show

The most direct side-by-side data come from the 1998 Novo Nordisk paper that introduced ipamorelin, which tested GHRP-2 and GHRP-6 as comparators [7]. In conscious swine:

  • GHRP-2 was more potent but less efficacious than GHRP-6: it took less GHRP-2 to produce a response, but the maximal GH response was lower.
  • Both GHRP-2 and GHRP-6 increased ACTH and cortisol. Ipamorelin did not, even at doses well above those needed for GH release.
  • None of the secretagogues tested changed FSH, LH, prolactin, or TSH in that swine model.

These findings explain why ipamorelin is often called the “selective” GH secretagogue, and why GHRP-2 and GHRP-6 are described as having a broader hormonal footprint. For researchers, the practical points are:

  • Studies that need to isolate GH: The ACTH/cortisol response to both GHRPs is a confounding variable that has to be controlled or measured.
  • Studies of the ghrelin and appetite axis: The appetite effects of GHRP-2 and GHRP-6 are part of what is being studied, not side effects to minimize.
  • Studies of GHRH and GHRP interaction: The synergy shown with GHRP-6 [4] is the basis for pairing GHRP-class and GHRH-class peptides, such as CJC-1295 with ipamorelin, in research.

“In GH-axis research, choosing a secretagogue is choosing which confounding variables you are willing to measure.”

What the Research Doesn’t Show Yet

  • Head-to-head GHRP-2 vs GHRP-6 data in humans are limited. Many comparisons rely on separate studies with different protocols.
  • Most mechanistic work comes from acute administration studies. Long-term receptor responsiveness is less well characterized.
  • Species differences matter. The swine potency data [7] may not transfer directly to rodent or cell models.

Explore GHRP-2, GHRP-6, and Related Research Peptides at BLL Peptides

BLL Peptides supplies research compounds that are third-party tested for identity and purity, with batch documentation available:

Related reading: Ipamorelin vs GHRP-6: Two Growth Hormone Secretagogues Compared · CJC-1295 Research: Pulsatile Growth Hormone Release · Peptide Half-Life Explained

All products are intended for research purposes only and are not intended for human consumption.

Frequently Asked Questions About GHRP-2 vs GHRP-6

Q: What is the main difference between GHRP-2 and GHRP-6?
Both are hexapeptide agonists of the ghrelin receptor (GHS-R1a). Comparative animal data show GHRP-2 is more potent, while GHRP-6 produced a higher maximal GH response in swine [7].

Q: Do GHRP-2 and GHRP-6 raise cortisol?
Yes. Both increased ACTH and cortisol in published studies, unlike the more selective ipamorelin [4][5][7].

Q: Which GHRP affects appetite more?
Both act on the ghrelin receptor and both are linked to appetite effects. GHRP-6 is widely recognized for this, and a human study found that GHRP-2 infusion increased food intake by about 36% versus saline [6].

Q: What is the natural ligand for the receptor GHRPs act on?
Ghrelin, a stomach-derived acylated peptide identified in 1999, three years after the receptor was cloned [1][2].

Q: Why are GHRPs studied alongside GHRH analogues?
GHRP-6 and GHRH released GH synergistically in human research, which suggests separate, complementary mechanisms [4].

References

  1. Howard AD, Feighner SD, Cully DF, et al. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science. 1996;273(5277):974-977. https://pubmed.ncbi.nlm.nih.gov/8688086/
  2. Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature. 1999;402(6762):656-660. https://pubmed.ncbi.nlm.nih.gov/10604470/
  3. Bowers CY, Momany FA, Reynolds GA, Hong A. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology. 1984;114(5):1537-1545. https://pubmed.ncbi.nlm.nih.gov/6714155/
  4. Bowers CY, Reynolds GA, Durham D, et al. Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. J Clin Endocrinol Metab. 1990;70(4):975-982. https://pubmed.ncbi.nlm.nih.gov/2108187/
  5. Arvat E, di Vito L, Maccagno B, et al. Effects of GHRP-2 and hexarelin, two synthetic GH-releasing peptides, on GH, prolactin, ACTH and cortisol levels in man. Peptides. 1997;18(6):885-891. https://pubmed.ncbi.nlm.nih.gov/9285939/
  6. Laferrère B, Abraham C, Russell CD, Bowers CY. Growth hormone releasing peptide-2 (GHRP-2), like ghrelin, increases food intake in healthy men. J Clin Endocrinol Metab. 2005;90(2):611-614. https://pubmed.ncbi.nlm.nih.gov/15699539/
  7. Raun K, Hansen BS, Johansen NL, et al. Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. 1998;139(5):552-561. https://pubmed.ncbi.nlm.nih.gov/9849822/

This content is intended for research and educational purposes only. It is not medical advice. GHRP-2 and GHRP-6 are not approved by the FDA for any human use. BLL Peptides products are not intended for human consumption.

Refer & Earn

highlight_off

Invite your friends and earn rewards!

Disclaimer: Peptides: This product is intended for laboratory research use only and is not approved for human consumption, medical, or veterinary use. Peptides are sold solely for research and development purposes by qualified professionals. Buyers are responsible for handling all materials in accordance with local regulations and safety guidelines. FDA Disclaimer: The statements made regarding these products have not been evaluated by the Food and Drug Administration. The efficacy of these products has not been confirmed by FDA-approved research. These products are not intended to diagnose, treat, cure, or prevent any disease.  
WAAVE Compliance